Want to see ALURD full AI Analyst Report?
ALURD Stock Chart & Stats
$4.60
-$0.05(-1.09%)
At close: 4:00 PM EDT
$4.60
-$0.05(-1.09%)
Day’s Range― - ―
52-Week Range$1.80 - $34.50
Previous CloseN/A
Volume522.00
Average Volume (3M)88.72K
Market Cap
$2.29M
Enterprise Value$33.40
Total Cash (Recent Filing)$5.06M
Total Debt (Recent Filing)$29.45M
Price to Earnings (P/E)―
Beta2.75
Next Earnings
Nov 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-56.40
Shares Outstanding1,000,417
10 Day Avg. Volume45,410
30 Day Avg. Volume88,723
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)-0.12
Price to Sales (P/S)0.61
P/FCF Ratio-0.32
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-20.25
Revenue Forecast (FY)$13.70M
Bulls Say, Bears Say
Bulls Say
Cost ManagementOperating expenses of $9.4M were down 48% year over year, as the company continues to closely control spending while prioritizing its growth initiatives.
Sales PerformanceQ3 sales were $2.7M vs the $2.1M Street estimate.
Strategic RealignmentALUR used the quarter to implement the strategy it outlined in August of realigning toward distributors with physician networks that prescribe GLP-1s.
Bears Say
Gross Margin DeclineQ3 gross margin was 49%, down from 58% last year due to the decline in sales and lower production volumes leading to less absorption of labor and overhead costs.
Revenue ShortfallRevenue was $3.4M, which fell short of the $5.2M consensus.
Sales ImpactSales were hurt by the intra-quarter decision to realign toward distributors with physician networks that prescribe GLP-1s.
Allurion Technologies News
ALURD FAQ
What was Allurion Technologies’s price range in the past 12 months?
Allurion Technologies lowest stock price was $1.80 and its highest was $34.50 in the past 12 months.
What is Allurion Technologies’s market cap?
Allurion Technologies’s market cap is $2.29M.
When is Allurion Technologies’s upcoming earnings report date?
Allurion Technologies’s upcoming earnings report date is Nov 18, 2026 which is in 88 days.
How were Allurion Technologies’s earnings last quarter?
Currently, no data Available
Is Allurion Technologies overvalued?
According to Wall Street analysts Allurion Technologies’s price is currently Overvalued.
Does Allurion Technologies pay dividends?
Allurion Technologies does not currently pay dividends.
What is Allurion Technologies’s EPS estimate?
Allurion Technologies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Allurion Technologies have?
Allurion Technologies has 1,000,417 shares outstanding.
What happened to Allurion Technologies’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Allurion Technologies?
Currently, no hedge funds are holding shares in ALURD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Allurion Technologies
Allurion Technologies Inc. focuses on developing a weight loss platform for overweight people in Spain, France, Turkey, and internationally. Its Allurion Program platform offers the Allurion Smart Capsule, a swallowable and procedure-less intragastric balloon for weight loss, and access to the Allurion Virtual Care Suite, a digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program. The company is headquartered in Natick, Massachusetts.
Technical Analysis
Ownership Overview
32.66% Insiders
3.61% Mutual Funds
― Other Institutional Investors
63.73% Public Companies and
Individual Investors